| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |